{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-002622","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2023-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.496921+00:00","generated_at":"2026-06-19T17:12:28.721634+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ARCA biopharma General Counsel Christopher Ozeroff to depart effective March 31, 2023","bullets":["Christopher D. Ozeroff, Secretary, SVP and General Counsel, to leave ARCA biopharma effective March 31, 2023.","Departure is mutual and not due to any disagreement with the company's operations or policies.","Will receive severance payments and COBRA reimbursement under existing employment agreement, conditioned on release of claims.","No replacement for General Counsel has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-002622","json":"https://secwatch.observer/filing/0000950170-23-002622.json","markdown":"https://secwatch.observer/filing/0000950170-23-002622.md","text":"https://secwatch.observer/filing/0000950170-23-002622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000095017023002622/0000950170-23-002622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000095017023002622/abio-20230210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T17:12:28.721634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5bb5e60d9f","claim":"Christopher D. Ozeroff departed as Secretary, Senior Vice President and General Counsel at Oruka Therapeutics, Inc..","evidence_excerpt":"ARCA biopharma, Inc. (“ARCA” or the \"Company\") and Christopher D. Ozeroff, the Secretary, Senior Vice President and General Counsel of ARCA have mutually agreed to conclude Mr. Ozeroff’s employment effective March 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/907654/000095017023002622/0000950170-23-002622-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"mutually agreed to conclude employment"},{"label":"Role","value":"Secretary, Senior Vice President and General Counsel"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}